human endogenous retrovirus np9 gene is over expressed in chronic lymphocytic leukemia patients
Clicks: 153
ID: 212995
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
153 views
12 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #14 of 15 articles by views in urology annals
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The human genome contains a large number of endogenous retroviruses (HERVs). Their reactivation has frequently been observed in patients with cancer. Considering their role in the carcinogenesis process, we aimed to study the possible relationship between HERVs gene expression and Chronic Lymphocytic Leukemia (CLL). We focused on two viral genes gag and np9, the latter presumably an oncogene. We found that the transcriptional activity of HERV-K np9 gene was greater in CLL patients than in healthy donors. However, gag expression was not significantly increased.
These findings suggest a noteworthy relationship between CLL disease and HERV-K np9 expression.
| Reference Key |
fischer2014leukemiahuman
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Sabrina Fischer;Natalia Echeverría;Gonzalo Moratorio;Ana Inés Landoni;Guillermo Dighiero;Juan Cristina;Pablo Oppezzo;Pilar Moreno |
| Journal | urology annals |
| Year | 2014 |
| DOI |
10.1016/j.lrr.2014.06.005
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.